Search Results - "Hospital, I"

Refine Results
  1. 1

    Prevalence of high, medium and low-risk medical conditions for pneumococcal vaccination in Catalonian middle-aged and older adults: a population-based study by Ochoa-Gondar, O, Hospital, I, Vila-Corcoles, A, Aragon, M, Jariod, M, de Diego, C, Satue, E

    Published in BMC public health (29-06-2017)
    “…Updated population-based data on the frequency and distribution of risk factors for pneumococcal disease is scarce. This study investigated the prevalence of…”
    Get full text
    Journal Article
  2. 2

    New evidence of risk factors for community-acquired pneumonia: a population-based study by Almirall, J, Bolibar, I, Serra-Prat, M, Roig, J, Hospital, I, Carandell, E, Agusti, M, Ayuso, P, Estela, A, Torres, A, Community-Acquired Pneumonia in Catalan Countries (PACAP) Study Group

    Published in The European respiratory journal (01-06-2008)
    “…The aim of the present study was to identify risk factors for community-acquired pneumonia (CAP), with special emphasis on modifiable risk factors and those…”
    Get full text
    Journal Article
  3. 3

    Incidence and Risk of Pneumococcal Pneumonia in Adults with Distinct Underlying Medical Conditions: A Population-Based Study by Vila-Corcoles, A., Ochoa-Gondar, O., Vila-Rovira, A., Aragon, M., Esteban-Julvez, L., Chamorro, N., Hospital, I., Satue, E., Blade, J., de Diego, C., Gomez-Bertomeu, F., Raga, X.

    Published in Lung (01-06-2020)
    “…Purpose This study investigated the incidence of pneumococcal pneumonia requiring hospitalisation among middle-aged and older adults with and without specific…”
    Get full text
    Journal Article
  4. 4

    Harnessing hepatitis B core-related antigen measurement to optimize posttreatment monitoring by Tsai, Ying-Nan, Wu, Jia-Ling, Hsu, Yao-Chun

    Published in Clinical and molecular hepatology (01-04-2024)
    “…[...]modeling a time-varying explanatory variable is distinctly different from analyzing changes between repeated measurements over time, as time-varying…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Evaluating the clinical effectiveness of pneumococcal vaccination in preventing myocardial infarction: The CAPAMIS study, three-year follow-up by Ochoa-Gondar, O, Vila-Corcoles, A, Rodriguez-Blanco, T, de Diego-Cabanes, C, Hospital-Guardiola, I, Jariod-Pamies, M

    Published in Vaccine (03-01-2014)
    “…Highlights • First prospective study using validated clinical data to evaluate relationships between pneumococcal vaccination and risk of myocardial…”
    Get full text
    Journal Article
  7. 7

    Inhaled drugs as risk factors for community-acquired pneumonia by ALMIRALL, J, BOLIBAR, I, TORRES, A, SERRA-PRAT, M, PALOMERA, E, ROIG, J, HOSPITAL, I, CARANDELL, E, AGUSTI, M, AYUSO, P, ESTELA, A

    Published in The European respiratory journal (01-11-2010)
    “…The effect of inhaled drugs in community-acquired pneumonia (CAP) is unclear. This case-control study was designed to determine whether inhaled drugs were risk…”
    Get full text
    Journal Article
  8. 8

    Validation of the CORB75 (confusion, oxygen saturation, respiratory rate, blood pressure, and age ≥75 years) as a simpler pneumonia severity rule by Ochoa-Gondar, O., Vila-Corcoles, A., Rodriguez-Blanco, T., Hospital, I., Salsench, E., Ansa, X., Saun, N.

    Published in Infection (01-04-2014)
    “…Purpose This study compares the ability of two simpler severity rules (classical CRB65 vs. proposed CORB75) in predicting short-term mortality in elderly…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Protective effect of pneumococcal vaccine against death by pneumonia in elderly subjects by Vila-Corcoles, A, Ochoa-Gondar, O, Llor, C, Hospital, I, Rodriguez, T, Gomez, A

    Published in The European respiratory journal (01-12-2005)
    “…The present study assessed the effectiveness of the 23-valent pneumococcal polysaccharide vaccine to prevent pneumonia and death in older adults in a…”
    Get full text
    Journal Article
  11. 11
  12. 12

    The intravenous injection of oxidized LDL- or Apolipoprotein B100 – Coupled splenocytes promotes Th1 polarization in wildtype and Apolipoprotein E – Deficient mice by Steinmetz, Martin, Ponnuswamy, Padmapriya, Laurans, Ludivine, Esposito, Bruno, Tedgui, Alain, Mallat, Ziad

    “…Th1 responses in atherosclerosis are mainly associated with the aggravation of atherosclerotic plaques, whereas Th2 responses lead to a less pronounced disease…”
    Get full text
    Journal Article
  13. 13

    Comparison of dose calculation algorithms in slab phantoms with cortical bone equivalent heterogeneities by Carrasco, P., Jornet, N., Duch, M. A., Panettieri, V., Weber, L., Eudaldo, T., Ginjaume, M., Ribas, M.

    Published in Medical physics (Lancaster) (01-08-2007)
    “…To evaluate the dose values predicted by several calculation algorithms in two treatment planning systems, Monte Carlo (MC) simulations and measurements by…”
    Get full text
    Journal Article
  14. 14
  15. 15

    Optimizing off-treatment outcome predictions: The potential of time-varying HBcrAg and the need for more research by Tsai, Ying-Nan, Wu, Jia-Ling, Hsu, Yao-Chun

    Published in Clinical and molecular hepatology (01-04-2024)
    “…[...]our data suggest the most recent HBcrAg level is more predictive than a previous measurement to guide posttreatment monitoring. [...]we agree with the…”
    Get full text
    Journal Article
  16. 16

    Aligning the Good Practice MASK With the Objectives of the European Innovation Partnership on Active and Healthy Ageing by Bousquet, J, Farrell, J, Illario, M

    Published in Allergy, asthma & immunology research (01-03-2020)
    “…The reference sites of the European Innovation Partnership on Active and Healthy Ageing (EIP on AHA) were renewed in 2019. The DG Santé good practice Mobile…”
    Get full text
    Journal Article
  17. 17

    Protective Effects of the 23-Valent Pneumococcal Polysaccharide Vaccine in the Elderly Population: The EVAN-65 Study by Vila-Córcoles, Angel, Ochoa-Gondar, Olga, Hospital, Imma, Ansa, Xabier, Vilanova, Angels, Rodríguez, Teresa, Llor, Carl

    Published in Clinical infectious diseases (01-10-2006)
    “…Background. The 23-valent polysaccharide pneumococcal vaccine (PPV) is currently recommended for elderly persons and persons who are at high risk of infection…”
    Get full text
    Journal Article
  18. 18

    Effects of annual influenza vaccination on winter mortality in elderly people with chronic heart disease by de Diego, Cinta, Vila-Córcoles, Angel, Ochoa, Olga, Rodriguez-Blanco, Teresa, Salsench, Elisabeth, Hospital, Imma, Bejarano, Ferran, del Puy Muniain, M., Fortin, Mercé, Canals, Montserrat

    Published in European heart journal (01-01-2009)
    “…Aims Although there is general agreement for the recommendation of the influenza vaccine to elderly and high-risk adults, the magnitude of clinical…”
    Get full text
    Journal Article
  19. 19
  20. 20

    The burden of community-acquired pneumonia in the elderly: the Spanish EVAN-65 study by Ochoa-Gondar, Olga, Vila-Córcoles, Angel, de Diego, Cinta, Arija, Victoria, Maxenchs, Monica, Grive, Montserrat, Martin, Enrique, Pinyol, Josep L

    Published in BMC public health (27-06-2008)
    “…Community-acquired pneumonia (CAP) is generally considered a major cause of morbidity and mortality in the elderly. However, population-based data are very…”
    Get full text
    Journal Article